ALTEROLA BIOTECH INC.Alterola Biotech Inc. • September 1st, 2022 • Medicinal chemicals & botanical products • Delaware
The purpose of this letter (the “Letter of Intent” or “LOI”) is to set forth: (A) the binding agreement of both parties regarding Bright Green Corporation’s acquisition of 25% of Alterola Biotech Inc., a Nevada Company traded on OTC Markets under the symbol “ABTI,” in exchange for a consideration of cash and consideration to be paid; and (B) the non-binding understanding of both parties regarding Alterola Biotech Inc.’s intent to irrevocably grant to Bright Green Corporation the right to purchase the remaining shares of Alterola Biotech Inc., on terms and conditions as set out in this Letter of Intent.
